Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

In this post hoc analysis we investigated the effects of insulin degludec/liraglutide fixed‐ratio combination (IDegLira) versus comparators on cardiovascular (CV) risk markers in participants in the DUAL II (vs. insulin degludec), DUAL V (vs. insulin glargine 100 units/mL) and DUAL VII (vs. basal–bo...

全面介紹

Na minha lista:
書目詳細資料
發表在:Diabetes Obes Metab
Main Authors: Vilsbøll, Tina, Blevins, Thomas C., Jodar, Esteban, Poulter, Neil, Tentolouris, Nikolaos, Ross Agner, Bue F., Lehmann, Lucine, Leiter, Lawrence A.
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2019
主題:
Brief Reports
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593827/
https://ncbi.nlm.nih.gov/pubmed/30785655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13675
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍